Journal Report

Drug Development Research

Download PDF
Journal Information
Journal Title
Drug Development Research
Publisher
John Wiley & Sons Inc.
ISSN
0272-4391
E-ISSN
1098-2299
Database
SCOPUS
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
SU5, a Stable Auraptene Analog, Ameliorates Metabolic Dysfunction‐Associated Steatohepatitis Through Modulation of the FXR Signaling Pathway
Fen Wen, Jing Chen, Lei Zhu et al.
2026-10-29 Vol. 87 Issue 7
Advancements in Natural Product‐Based Ischemic Stroke Treatment: Mechanisms, Key Compounds, and Drug Delivery Systems
Nan Yang, Mengmeng Li, Min Wang et al.
2026-10-29 Vol. 87 Issue 7
From Conventional to Nano‐Enabled Combination Therapies to Address Therapeutic Challenges of Malaria
Maha Mohammad Eissa, Eman Fathi Fadel
2026-10-28 Vol. 87 Issue 7
The Rise of Agentic AI and Self‐Driving Laboratories: Reshaping Drug Discovery, Development, and Precision Medicine
Bhagyashri Rathod, Manish Baviskar, Sachin Puri
2026-10-28 Vol. 87 Issue 7
Recent Progress in HDAC‐Based Dual‐Target Inhibitors for Colorectal Cancer
Jiaqi Yang, Xinyu Shi, Yang Xu et al.
2026-10-28 Vol. 87 Issue 7
Coptisine Protects Against Cisplatin‐Induced Acute Kidney Injury With Involvement of PI3K/Akt Signaling
Chunyan Liu, Shukun Chen, Yan He et al.
2026-10-23 Vol. 87 Issue 7
Exploiting <i>Plasmodium</i> Mitochondrial Pathways for Next‐Generation Antimalarial Drug Development: Prospects and Updates
Rohit Nehra, Kuldeep Singh, Himmat Singh et al.
2026-10-23 Vol. 87 Issue 7
Advancements of Emerging Thiazole‐Based CDKs Inhibitors for Cancer Therapy: From Hits to Clinical Candidates
Menglin Luo, Shuwang Jiang, Yufeng Ma et al.
2026-10-22 Vol. 87 Issue 7
Correction to “Mesalamine in Treatment of Intestinal Inflammatory Diseases—Formulation‐Driven Strategies for Targeted Colonic Therapy and Remission Maintenance”
2026-10-11 Vol. 87 Issue 7
Bavachin Attenuates Cognitive Impairment in Scopolamine‐Induced Amnesia: Behavioral, Biochemical and Molecular Insights
Md. Shadin, Monisha Brati Barua, Talat Ali et al.
2026-10-9 Vol. 87 Issue 7
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 1, 2026 07:55